Effect of Hydrogen-rich Water During Tapering on Recovery After Functional Overreaching in Basketball Players

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-35
SponsorPalacky University

About this trial

The goal of this clinical trial is to evaluate whether hydrogen-rich water supplementation during tapering improves recovery after functional overreaching in competitive male basketball players aged 18-35 years. The main questions it aims to answer are:

* Does hydrogen-rich water improve autonomic recovery after functional overreaching? * Does hydrogen-rich water improve recovery in biochemical, performance, and subjective feeling outcomes during tapering?

Researchers will compare hydrogen-rich water to placebo (water containing no molecular hydrogen) to determine whether molecular hydrogen improves recovery after accumulated fatigue has been induced by functional overreaching. Participants will:

* Complete a training cycle including normal training, functional overreaching, and tapering. * Consume hydrogen-rich or placebo water daily during the one-week tapering period. * Undergo repeated testing of autonomic nervous system, blood biochemical markers, performance, and subjective soreness.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Competitive male basketball players.

Signed informed consent.

Completion of entry medical and laboratory screening.

Disqualifiers

Acute injury or infection.

History or presence of relevant cardiovascular, respiratory, metabolic, or other disease that may affect the study results.

Use of medication affecting recovery markers or study results.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Hydrogen-rich water

    Dietary supplement

    Hydrogen-rich water with molecular hydrogen concentration \>1.0 ppm.

  • Placebo water

    Dietary supplement

    Tap water without molecular hydrogen.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: Hydrogen-rich waterExperimental treatment 1 intervention
Group B: Placebo waterPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

RMSSD

The root mean square of successive differences of RR intervals (RMSSD) is used as an index of parasympathetic activity and is calculated from an ECG using heart rate variability analysis.

Time frame
One-week change between post-overreaching and post-taper.

Secondary outcomes

1

Creatine kinase

Blood creatine kinase concentration is used as a marker of muscle damage.

Time frame
One-week change between post-overreaching and post-taper.
2

High-sensitivity C-reactive protein

High-sensitivity C-reactive protein concentration is used as a marker of systemic inflammatory.

Time frame
One-week change between post-overreaching and post-taper.
3

Cortisol

Blood cortisol concentration is used as a marker of physiological stress response.

Time frame
One-week change between post-overreaching and post-taper.
4

Testosterone

Blood testosterone concentration is used as a marker related to anabolic-catabolic balance.

Time frame
One-week change between post-overreaching and post-taper.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.